Drug Shortage Report for APO-DILTIAZ CD

Last updated on 2018-12-18 History
Report ID 287
Drug Identification Number 02229526
Brand name APO-DILTIAZ CD - CAP 300MG
Common or Proper name DILTIAZEM
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-02-06
Estimated end date Unknown
Actual end date 2018-12-17
Shortage status Resolved
Updated date 2018-12-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-10 English Compare
v2 2017-03-10 French Compare
v3 2018-12-18 English Compare
v4 2018-12-18 French Compare

Showing 1 to 4 of 4